What’s more, the algorithm can correctly localize three out of four of the interval cancers it detects.

Biennial and intermittent screening also significantly decrease rates of overall survival, a new analysis shows.

The FDA’s current draft guidance on the approval process for AI devices does not specify the type of validation the agency recommends manufacturers use. 

Since the onset of the iodinated contrast shortage in 2022, countless tactics have been deployed to optimize use of the imaging agent, but many have been overlooked.

The method also reduces radiation doses and eliminates the need for sedation or general anesthesia.

Women are considered especially vulnerable to this statistic, as they are more likely to partake in part-time training, a new analysis shows.